Mesoblast Limited (MEOBF)
OTCMKTS · Delayed Price · Currency is USD
0.9650
0.00 (0.00%)
At close: Jun 23, 2025
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.93 billion as of July 22, 2025. Its market cap has increased by 124.08% in one year.
Market Cap
1.93B
Enterprise Value
2.02B
Revenue
5.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.97
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 57.91M to 1.93B, an increase of 3,235.53%. That is a compound annual growth rate of 18.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.61B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 599.09M |
| Glass House Brands | 434.24M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 386.15M |